Jiangsu Aidea Pharmaceutical Co Ltd banner
J

Jiangsu Aidea Pharmaceutical Co Ltd
SSE:688488

Watchlist Manager
Jiangsu Aidea Pharmaceutical Co Ltd
SSE:688488
Watchlist
Price: 15.93 CNY -3.4% Market Closed
Market Cap: ¥6.7B

Wall St Price Targets

Price Targets Summary
Jiangsu Aidea Pharmaceutical Co Ltd

There are no price targets for Jiangsu Aidea Pharmaceutical Co Ltd.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Jiangsu Aidea Pharmaceutical Co Ltd Competitors:
Price Targets
ULTA
Ulta Beauty Inc
17% Upside

Revenue
Forecast

15% / Year
Past Growth
31% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
15% / Year
Past Growth
31% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 7 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 2 years is 31%.

Gross Profit
Forecast

23% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
23% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Jiangsu Aidea Pharmaceutical Co Ltd

Operating Income
Forecast

32% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
32% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Operating Income Forecast
is not available for Jiangsu Aidea Pharmaceutical Co Ltd

Pre-Tax Income
Forecast

19% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
19% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Jiangsu Aidea Pharmaceutical Co Ltd

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Net Income Forecast
is not available for Jiangsu Aidea Pharmaceutical Co Ltd
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Jiangsu Aidea Pharmaceutical Co Ltd's stock price target?
Not Available

Jiangsu Aidea Pharmaceutical Co Ltd does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Jiangsu Aidea Pharmaceutical Co Ltd?
Projected CAGR
31%

Over the last 7 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 2 years is 31%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett